Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

C Thomssen

Showing results (21-30 of 71) with videos related to

Pageof 8
Sort By:
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|July 1, 1995
Prognostic value of the cysteine proteases cathepsins B and cathepsin L in human breast cancerC Thomssen, M Schmitt, L Goretzki, et al.
British Journal of Cancer|January 1, 1997
Time-varying prognostic impact of tumour biological factors urokinase (uPA), PAI-1 and steroid hormone receptor status in primary breast cancerM Schmitt, C Thomssen, K Ulm, et al.
Oncology (Williston Park, N.Y.)|March 28, 1998
Metastatic breast cancer: experience with the combination paclitaxel plus epirubicinH J Lück, C Thomssen, A Du Bois, et al.
Journal of Cancer Research and Clinical Oncology|April 10, 2020
Knowledge transfer as a tool towards improvement of cancer care in low- and middle-income countries. 6th European Roundtable Meeting (ERTM), June 14th, 2019, Berlin, GermanyO Ortmann, J Torode, W Schmiegel, et al.
International Journal of Cancer|July 9, 1991
Occurrence of antibodies to L1, L2, E4 and E7 gene products of human papillomavirus types 6b, 16 and 18 among cervical cancer patients and controlsH G Köchel, M Monazahian, K Sievert, et al.
The International Journal of Biological Markers|April 14, 2000
Long-term follow-up confirms prognostic impact of PAI-1 and cathepsin D and L in primary breast cancerN Harbeck, U Alt, U Berger, et al.
Anticancer Research|August 15, 1998
Identification of low-risk node-negative breast cancer patients by tumor biological factors PAI-1 and cathepsin LC Thomssen, P Oppelt, F Jänicke, et al.
The International Journal of Biological Markers|October 3, 2006
Clinical utility of determination of HER-2/neu and EGFR fragments in serum of patients with metastatic breast cancerI Witzel, C Thomssen, S Krenkel, et al.
The British Journal of Radiology|June 6, 2012
Primary and secondary breast lymphoma: prevalence, clinical signs and radiological featuresA Surov, H-J Holzhausen, A Wienke, et al.
Zentralblatt Fur Gynakologie|January 11, 2007
[Breast cancer: analysis of treatment quality in Germany 2004: retrospective survey by Arbeitsgemeinschaft Gynäkologische Onkologie (AGO)]C Jackisch, M Untch, D Chatsiproios, et al.
Pageof 8

Showing results (21-30 of 71) with videos related to

Sort By:
Pageof 8
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|July 1, 1995
Prognostic value of the cysteine proteases cathepsins B and cathepsin L in human breast cancerC Thomssen, M Schmitt, L Goretzki, et al.
British Journal of Cancer|January 1, 1997
Time-varying prognostic impact of tumour biological factors urokinase (uPA), PAI-1 and steroid hormone receptor status in primary breast cancerM Schmitt, C Thomssen, K Ulm, et al.
Oncology (Williston Park, N.Y.)|March 28, 1998
Metastatic breast cancer: experience with the combination paclitaxel plus epirubicinH J Lück, C Thomssen, A Du Bois, et al.
Journal of Cancer Research and Clinical Oncology|April 10, 2020
Knowledge transfer as a tool towards improvement of cancer care in low- and middle-income countries. 6th European Roundtable Meeting (ERTM), June 14th, 2019, Berlin, GermanyO Ortmann, J Torode, W Schmiegel, et al.
International Journal of Cancer|July 9, 1991
Occurrence of antibodies to L1, L2, E4 and E7 gene products of human papillomavirus types 6b, 16 and 18 among cervical cancer patients and controlsH G Köchel, M Monazahian, K Sievert, et al.
The International Journal of Biological Markers|April 14, 2000
Long-term follow-up confirms prognostic impact of PAI-1 and cathepsin D and L in primary breast cancerN Harbeck, U Alt, U Berger, et al.
Anticancer Research|August 15, 1998
Identification of low-risk node-negative breast cancer patients by tumor biological factors PAI-1 and cathepsin LC Thomssen, P Oppelt, F Jänicke, et al.
The International Journal of Biological Markers|October 3, 2006
Clinical utility of determination of HER-2/neu and EGFR fragments in serum of patients with metastatic breast cancerI Witzel, C Thomssen, S Krenkel, et al.
The British Journal of Radiology|June 6, 2012
Primary and secondary breast lymphoma: prevalence, clinical signs and radiological featuresA Surov, H-J Holzhausen, A Wienke, et al.
Zentralblatt Fur Gynakologie|January 11, 2007
[Breast cancer: analysis of treatment quality in Germany 2004: retrospective survey by Arbeitsgemeinschaft Gynäkologische Onkologie (AGO)]C Jackisch, M Untch, D Chatsiproios, et al.
Pageof 8